Friedrich Holz and Jonathan Tedder to oversee Wilson, N.C. facility as company plans to expand tube production into cosmetics sector in 2024.
Wilson, North Carolina, USA – Hoffmann Neopac, a global provider of high-quality packaging and dosing applications for pharma, beauty and oral care, has appointed two new Co-Directors to lead its U.S. facility in Wilson, North Carolina, which until recently focused mostly on small diameter tubes for the pharmaceutical sector. Friedrich Holz was hired as Director of Finance & Administration and will co-lead the facility alongside Jonathan Tedder, who was promoted to Director of Operations. The appointments come as the company plans to significantly increase its tube production capacity in 2024, including a new focus on larger diameter tubes applicable to the cosmetics sector.
For Neopac, its U.S. facility’s expanded market focus will entail the installation of a new tube line producing tubes 25-40mm in diameter, with an output capacity of 40 million tubes annually. The line will mainly target the consumer health and cosmetic industries, manufacturing both high barrier Polyfoil® and recyclable Polyfoil® MMB mono-material tubes.
Mr. Holz joins Hoffmann Neopac with more than 20 years of experience in managing internal controls and financial operations within the manufacturing industry. Most recently, he was Chief Financial Officer at Haag-Streit, a medical device company in the eyecare field. Prior to that, Mr. Holz held numerous senior-level finance positions for more than a decade at Silicon Microstructures, Inc., a manufacturer of high-end pressure sensors for automotive, medical and industrial applications.
Mr. Tedder joined Hoffmann Neopac in 2019 as Head of Production, and for several years oversaw the Wilson plant’s machinery to ensure safety, quality and productivity. He was promoted to his new role of Director of Operations in May 2023.
Mr. Holz and Mr. Tedder’s new roles coincide with the retirement of outgoing Managing Director, Douglas Voreis, whose tenure was both lengthy and successful. Mr. Voreis’ accomplishments included overseeing the U.S. facility’s initial build and ramp-up as it began and expanded production of small-diameter pharmaceutical tubes.
“As we say farewell to Douglas, who served the company with dedication for five years, we are grateful for his stewardship that helped us further our presence in the North American marketplace,” said Mark Aegler, CEO at Hoffmann Neopac. “We are confident that Friedrich’s and Jonathan’s extensive backgrounds and prior accomplishments will help us achieve our growth targets in Wilson, including the addition of a new cosmetic line for sustainable cosmetic tube solutions that broadens our American-made portfolio.”
